IL147093A0 - Retro-inverso peptides derived from interleukin-3 - Google Patents

Retro-inverso peptides derived from interleukin-3

Info

Publication number
IL147093A0
IL147093A0 IL14709300A IL14709300A IL147093A0 IL 147093 A0 IL147093 A0 IL 147093A0 IL 14709300 A IL14709300 A IL 14709300A IL 14709300 A IL14709300 A IL 14709300A IL 147093 A0 IL147093 A0 IL 147093A0
Authority
IL
Israel
Prior art keywords
retro
interleukin
peptides derived
inverso peptides
inverso
Prior art date
Application number
IL14709300A
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of IL147093A0 publication Critical patent/IL147093A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL14709300A 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-3 IL147093A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13968899P 1999-06-16 1999-06-16
PCT/US2000/016759 WO2000077028A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-3

Publications (1)

Publication Number Publication Date
IL147093A0 true IL147093A0 (en) 2002-08-14

Family

ID=22487853

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14709300A IL147093A0 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-3
IL147093A IL147093A (en) 1999-06-16 2001-12-13 Retro-inverso peptide derived from interleukin-3

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147093A IL147093A (en) 1999-06-16 2001-12-13 Retro-inverso peptide derived from interleukin-3

Country Status (6)

Country Link
EP (1) EP1185552A1 (en)
JP (2) JP2003502340A (en)
AU (1) AU5496500A (en)
CA (1) CA2376394A1 (en)
IL (2) IL147093A0 (en)
WO (1) WO2000077028A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
EP2095823A1 (en) * 2002-07-30 2009-09-02 Stem Cell Therapeutics Inc. GM-CSF for treating demyelination
WO2004035086A2 (en) * 2002-10-16 2004-04-29 Hunter Samuel F Method for treatment of demyelinating central nervous system disease using gm-csf
US7695723B2 (en) * 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
EP0979238A4 (en) * 1997-03-05 2000-08-23 Univ California Method of alleviating neuropathic pain
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
JP2011137019A (en) 2011-07-14
AU5496500A (en) 2001-01-02
WO2000077028A1 (en) 2000-12-21
IL147093A (en) 2011-04-28
EP1185552A1 (en) 2002-03-13
CA2376394A1 (en) 2000-12-21
JP2003502340A (en) 2003-01-21

Similar Documents

Publication Publication Date Title
HK1036997A1 (en) Peptides
GB0128994D0 (en) Peptides
EP1173467A4 (en) Chemokine-derived synthetic peptides
GB9929464D0 (en) Complementary peptide ligande generated from the human genome
GB9918156D0 (en) Synthetic peptides
GB9825854D0 (en) Peptide
HK1042307A1 (en) Peptide having preptin functionality
EP1147130A4 (en) Alpha-conotoxin peptides
GB9812675D0 (en) Peptides
IL150458A0 (en) Novel haptotactic peptides
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
EP1159288A4 (en) Alpha-conotoxin peptides
GB9904695D0 (en) Peptide
IL147095A0 (en) Retro-inverso peptides derived from leukemia inhibitory factor
IL144376A0 (en) Peptides
GB9908920D0 (en) Peptide
IL147094A0 (en) Retro-inverso peptides derived from interleukin-6
GB9807890D0 (en) Peptides
EP1151100A4 (en) Tau-conotoxin peptides
GB9928325D0 (en) Peptides
GB9907911D0 (en) Peptides
GB9918599D0 (en) Novel peptides
GB9918606D0 (en) Novel peptides
GB9918601D0 (en) Novel peptides
GB9918593D0 (en) Novel peptides